| [1] |
Overgaard M, Hansen PS, Overgaard J, et al. Postoperative radiotherapy in high-risk premenopausal women with breast cancer who receive adjuvant chemotherapy. Danish Breast Cancer Cooperative Group 82b Trial[J]. N Engl J Med,1997,337(14):949-955.
|
| [2] |
Overgaard M, Jensen MB, Overgaard J, et al. Postoperative radiotherapy in high-risk postmenopausal breast-cancer patients given adjuvant tamoxifen: Danish Breast Cancer Cooperative Group DBCG 82c randomised trial[J]. Lancet,1999,353(9165):1641-1648.
|
| [3] |
Clarke M, Collins R, Darby S, et al. Early Breast Cancer Trialists’ Collaborative Group (EBCTCG). Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials [J]. Lancet,2005,366(9503):2087-2106.
|
| [4] |
Kunkler I. Adjuvant chest wall radiotherapy for breast cancer:black, white and shades of grey[J]. Eur J Surg Oncol,2010,36(4):331-334.
|
| [5] |
National Comprehensive Cancer Network. NCCN Clinical practice guidelines in oncology -Breast Cancer Version v3.2013[DB/OL]. [2013-03-20]. http:/ /www.nccn.org/professionals/physician_gls/pdf/breast.pdf.
|
| [6] |
Truong PT, Lesperance M, Culhaci A, et al. Patient subsets with T1-T2, node-negative breast cancer at high locoregional recurrence risk after mastectomy[J]. Int J Radiat Oncol Biol Phys,2005,62(1):175-182.
|
| [7] |
Jagsi R, Raad RA, Goldberg S, et al. Locoregional recurrence rates and prognostic factors for failure in node-negative patients treated with mastectomy: implications for postmastectomy radiation[J]. Int J Radiat Oncol Biol Phys, 2005,62(4):1035-1039.
|
| [8] |
Abi-Raad R, Boutrus R, Wang R, et al. Patterns and risk factors of locoregional recurrence in T1-T2 node negative breast cancer patients treated with mastectomy: implications for postmastectomy radiotherapy[J]. Int J Radiat Oncol Biol Phys,2011,81(3):e151-e157.
|
| [9] |
Wallgren A, Bonetti M, Gelber RD, et al. Risk factors for locoregional recurrence among breast cancer patients: results from International Breast Cancer Study Group Trials I throughⅦ[J]. J Clin Oncol,2003,21(7):1205-1213.
|
| [10] |
Rowell NP. Radiotherapy to the chest wall following mastectomy for node-negative breast cancer: a systematic review [J].Radiother Oncol,2009,91(1):23-32.
|
| [11] |
Abdulkarim BS, Cuartero J, Hanson J, et al. Increased risk of locoregional recurrence for women with T1-2 N0 triple-negative breast cancer treated with modified radical mastectomy without adjuvant radiation therapy compared with breast-conserving therapy[J]. J Clin Oncol,2011,29(21):2852-2858.
|
| [12] |
Floyd SR, Buchholz TA, Haffty BG, et al. Low local recurrence rate without postmastectomy radiation in nodenegative breast cancer patients with tumors 5 cm and larger[J].Int J Radiat Oncol Biol Phys,2006,66(2):358-364.
|
| [13] |
Floyd SR, Taghian AG. Post-mastectomy radiation in large node-negative breast tumors: does size really matter? [J].Radiother Oncol,2009,91(1):33-37.
|
| [14] |
Nagar H, Mittendorf EA, Strom EA, et al. Local-regional recurrence with and without radiation therapy after neoadjuvant chemotherapy and mastectomy for clinically staged T3N0 breast cancer[J]. Int J Radiat Oncol Biol Phys,2011,81(3):782-787.
|
| [15] |
Overgaard M, Nielsen HM, Overgaard J. Is the benefit of postmastectomy irradiation limited to patients with four or more positive nodes, as recommended in international consensus reports? A subgroup analysis of the DBCG 82 b&c randomized trials[J]. Radiother Oncol,2007,82(3):247-253.
|
| [16] |
Cheng JC, Chen CM, Liu MC, et al. Locoregional failure of postmastectomy patients with 1-3 positive axillary lymph nodes without adjuvant radiotherapy[J]. Int J Radiat Oncol Biol Phys,2002,52(4):980-988.
|
| [17] |
Cosar R, Uzal C, Tokatli F, et al. Postmastectomy irradiation in breast in breast cancer patients with T1-2 and 1-3 positive axillary lymph nodes:is there a role for radiation therapy?[J].Radiat Oncol,2011,6:28.
|
| [18] |
王淑莲, 余子豪,李晔雄,等. T1 ～T2 期伴1 ～3 个腋窝淋巴结转移乳腺癌患者改良根治术后放疗的作用[J]. 中华放射肿瘤学杂志,2009,18(4):291-294.
|
| [19] |
Katz A, Strom EA, Buchholz TA, et al. Locoregional recurrence patterns after mastectomy and doxorubicin-based chemotherapy: implications for postoperative irradiation[J]. J Clin Oncol,2000,18(15):2817-2827.
|
| [20] |
Jagsi R, Raad RA, Goldberg S, et al. Locoregional recurrence rates and prognostic factors for failure in node-negative patients treated with mastectomy: implications for postmastectomy radiation[J]. Int J Radiat Oncol Biol Phys, 2005, 62(4):1035-1039
|
| [21] |
Katz A, Strom EA, Buchholz TA, et al. The influence of pathologic tumor characteristics on locoregional recurrence rates following mastectomy[J]. Int J Radiat Oncol Biol Phys,2001,50(3):735-742.
|
| [22] |
Katz A,Buchholz TA, Thames H,et al. Recursive partitioning analysis of locoregional recurrence patterns following mastectomy: implications for adjuvant irradiation[J]. Int J Radiat Oncol Biol Phys,2001,50(2):397-403.
|
| [23] |
Truong PT, Olivotto IA, Kader HA, et al. Selecting breast cancer patients with T1-T2 tumors and one to three positive axillary nodes at high postmastectomy locoregional recurrence risk for adjuvant radiotherapy[J]. Int J Radiat Oncol Biol Phys,2005,61(5):1337-1347.
|
| [24] |
Botteri E, Gentilini O, Rotmensz N, et al. Mastectomy without radiotherapy: outcome analysis after 10 years of follow-up in a single institution[J]. Breast Cancer Res Treat,2012,134(3):1221-1228.
|
| [25] |
Kunkler IH, Canney P, van Tienhoven G, et al. Elucidating the role of chest wall irradiation in ‘intermediate-risk’ breast cancer: the MRC/EORTC SUPREMO trial[J]. Clin Oncol (R Coll Radiol),2008,20(1):31-34.
|
| [26] |
Huang EH, Tucker SL, Strom EA, et al. Postmastectomy radiation improves local-regional control and survival for selected patients with locally advanced breast cancer treated with neoadjuvant chemotherapy and mastectomy[J]. J Clin Oncol,2004,22(23):4691-4699.
|
| [27] |
Huang EH, Tucker SL, Strom EA, et al. Predictors of locoregional recurrence in patients with locally advanced breast cancer treated with neoadjuvant chemotherapy, mastectomy,and radiotherapy[J]. Int J Radiat Oncol Biol Phys,2005,62(2):351-357.
|
| [28] |
Fowble BL, Einck JP, Kim DN, et al. Role of postmastectomy radiation after neoadjuvant chemotherapy in stage Ⅱ-Ⅲbreast cancer[J]. Int J Radiat Oncol Biol Phys, 2012, 83(2):494-503.
|
| [29] |
Chang DT, Feigenberg SJ, Indelicato DJ, et al. Long-term outcomes in breast cancer patients with ten or more positive axillary nodes treated with combined-modality therapy: the importance of radiation field selection[J]. Int J Radiat Oncol Biol Phys,2007,67(4):1043-1051.
|
| [30] |
Botteri E, Gentilini O, Rotmensz N, et al. Mastectomy without radiotherapy: outcome analysis after 10 years of follow-up in a single institution[J]. Breast Cancer Res Treat, 2012, 134(3):1221-1228.
|
| [31] |
Veronesi U, Cascinelli N, Greco M, et al. Prognosis of breast cancer patients after mastectomy and dissection of internal mammary nodes[J]. Ann Surg,1985,202(6):702-707.
|
| [32] |
Fowble B, Hanlon A, Freedman G, et al. Internal mammary node irradiation neither decreases distant metastases nor improves survival in stage Ⅰand Ⅱbreast cancer[J]. Int J Radiat Oncol Biol Phys,2000,47(4):883-894.
|
| [33] |
Galimberti V, Veronesi P, Arnone P, et al. Stage migration after biopsy of internal mammary chain lymph nodes in breast cancer patients[J]. Ann Surg Oncol,2002,9(9):924-928.
|
| [34] |
Freedman GM, Fowble BL, Nicolaou N, et al. Should internal mammary lymph nodes in breast cancer be a target for the radiation oncologist? [J]. Int J Radiat Oncol Biol Phys,2000,46(4):805-814.
|
| [35] |
Eubank WB, Mankoff DA, Takasugi J, et al.18fluorodeoxyglucose positron emission tomography to detect mediastinal or internal mammary metastases in breast cancer[J]. J Clin Oncol,2001,19(15):3516-3523.
|
| [36] |
Zhang YJ, Oh JL, Whitman GJ, et al. Clinically apparent internal mammary nodal metastasis in patients with advanced breast cancer: incidence and local control[J]. Int J Radiat Oncol Biol Phys,2010,77(4):1113-1119.
|
| [37] |
Lievens Y, Poortmans P, Van den Bogaert W. A glance on quality assurance in EORTC study 22922 evaluating techniques for internal mammary and medial supraclavicular lymph node chain irradiation in breast cancer[J]. Radiother Oncol,2001,60(3):257-265.
|
| [38] |
Stemmer SM, Rizel S, Hardan I, et al. The role of irradiation of the internal mammary lymph nodes in high-risk stage Ⅱto ⅢA breast cancer patients after high-dose chemotherapy: a prospective sequential nonrandomized study[J]. J Clin Oncol,2003,21(14):2713-2718.
|
| [39] |
Lohrisch C, Jackson J, Jones A, et al. Relationship between tumor location and relapse in 6781 women with early invasive breast cancer[J]. J Clin Oncol,2000,18(15):2828-2835.
|
| [40] |
Huang O,Wang L,Shen K,et al. Breast cancer subpopulation with high risk of internal mammary lymph nodes metastasis:analysis of 2,269 Chinese breast cancer patients treated with extended radical mastectomy[J]. Breast Cancer Res Treat,2008,107(3):379-387.
|
| [41] |
Whelan TJ,Olivotto I,Ackerman I,et al. NCIC-CTG MA.20:An intergroup trial of regional nodal irradiation in early breast cancer[J]. J Clin Oncol,2011,29(18 Suppl):S1003.
|
| [42] |
Cuzick J, Stewart H, Peto R, et al. Overview of randomized trials comparing radical mastectomy without radiotherapy against simple mastectomy with radiotherapy in breast cancer[J].Cancer Treat Rep,1987,71(1):7-14.
|
| [43] |
Krueger EA, Fraass BA, Pierce LJ. Clinical aspects of intensity-modulated radiotherapy in the treatment of breast cancer[J]. Semin Radiat Oncol,2002,12(3):250-259.
|
| [44] |
Shiau AC, Chiu MC, Chen TH, et al. Surface and superficial dose dosimetric verification for postmastectomy radiotherapy[J]. Med Dosim,2012,37(4):417-424.
|
| [45] |
Krueger EA,Fraass BA,McShan DL, et al. Potential gains for irradiation of chest wall and regional nodes with intensity modulated radiotherapy[J]. Int J Radiat Oncol Biol Phys,2003,56(4):1023-1037.
|
| [46] |
Baycan D, Karacetin D, Balkanay AY, et al. Field-in-field IMRT versus 3D-CRT of the breast. Cardiac vessels, ipsilateral lung, and contralateral breast absorbed doses in patients with left-sided lumpectomy: a dosimetric comparison[J]. Jpn J Radiol,2012,30(10):819-823.
|
| [47] |
张桂芳,卢洁,王传栋,等.乳腺癌根治术后两种调强放疗模式的剂量学研究[J]. 中华放射医学与防护杂志, 2011,31(4):456-459.
|
| [48] |
Gauer T, Engel K, Kiesel A, et al. Comparison of electron IMRT to helical photon IMRT and conventional photon irradiation for treatment of breast and chest wall tumours[J].Radiother Oncol,2010,94(3):313-318.
|
| [49] |
Salguero FJ, Palma B, Arrans R, et al. Modulated electron radiotherapy treatment planning using a photon multileaf collimator for post-mastectomized chest walls[J]. Radiother Oncol,2009,93(3):625-632.
|